| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/03/2011 | US20110028465 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 02/03/2011 | US20110028464 Inhibitors of human immunodeficiency virus replication |
| 02/03/2011 | US20110028463 Amide compounds |
| 02/03/2011 | US20110028462 Niacin Receptor Agonists, compositions Containing Such Compounds and Methods of Treatment |
| 02/03/2011 | US20110028461 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 02/03/2011 | US20110028460 Topical formulation |
| 02/03/2011 | US20110028459 Wound Healing |
| 02/03/2011 | US20110028458 Inhibition of cell migration by a farnesylated dibenzodiazepinone |
| 02/03/2011 | US20110028457 Pharmaceutical preparation comprising permethylated cyclodextrin |
| 02/03/2011 | US20110028456 Solid Pharmaceutical Dosage Form |
| 02/03/2011 | US20110028455 Indole-substituted 3-cyanopyridines As Kinase Inhibitors |
| 02/03/2011 | US20110028454 Deuterium-enriched bazedoxifene |
| 02/03/2011 | US20110028453 Treating Negative Symptoms of Schizophrenia Associated with Defective Neuregulin 1 |
| 02/03/2011 | US20110028452 PYRIDO[4,3-d]PYRIMIDIN-4(3H)-ONE DERIVATIVES AS CALCIUM RECEPTOR ANTAGONISTS |
| 02/03/2011 | US20110028451 Dihydrobenzoindazoles |
| 02/03/2011 | US20110028450 Ring-annulated dihydropyrrolo[2,1-alpha]isoquinolines |
| 02/03/2011 | US20110028449 Novel aminomethyl benzene derivatives |
| 02/03/2011 | US20110028448 Pyridine compounds |
| 02/03/2011 | US20110028447 Indazole derivatives |
| 02/03/2011 | US20110028446 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 02/03/2011 | US20110028445 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 02/03/2011 | US20110028444 Pharmaceutically acceptable salts of anti-infection quinolone compounds |
| 02/03/2011 | US20110028442 Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the beta2 adrenergic receptor |
| 02/03/2011 | US20110028441 Novel phenyl-substituted piperazino-dihydrothienopyrimidines |
| 02/03/2011 | US20110028440 Simultaneous Method for the Preparation of a Mixture of 3-acetoxy-17-acetamido-16-formyl-androst-5,17-diene and 3-acetoxy-2'-chloro-5-androsteno[17,16-b]pyridine |
| 02/03/2011 | US20110028439 Combination hormone replacement therapy (HRT) and melatonin to prevent and treat mammary cancer |
| 02/03/2011 | US20110028438 Medical use of 3-2,2,2-trimethylhydrazinium propionate salts. |
| 02/03/2011 | US20110028437 Phosphorylated pyrone analogs and methods |
| 02/03/2011 | US20110028436 Oral combination of vitamins |
| 02/03/2011 | US20110028435 Crystallization method and bioavailability |
| 02/03/2011 | US20110028434 Long-chain polyunsaturated fatty acids (lc-pufa) in maternal nutrition during pregnancy and lactation |
| 02/03/2011 | US20110028433 Quinazolinone derivatives as tubulin polymerization inhibitors |
| 02/03/2011 | US20110028432 Use of cyclodextrin for treatment and prevention of bronchial inflammatory diseases |
| 02/03/2011 | US20110028431 Oral mucoadhesive dosage form |
| 02/03/2011 | US20110028430 Injectable viscous medicinal preparation comprising ethanol and an x-ray opaque fat-soluble compound |
| 02/03/2011 | US20110028429 Combination of polychitosamine and hmg-coa reductase inhibitor for hyperlipidemia |
| 02/03/2011 | US20110028428 Hirsutella sinensis mycelia compositions and methods for treating sepsis and related inflammatory responses |
| 02/03/2011 | US20110028427 Dietary fiber and method for preparing dietary fiber |
| 02/03/2011 | US20110028426 Dewatering biomass material comprising polysaccharide, method for extracting polysaccharide from biomass material, and dewatered biomass material |
| 02/03/2011 | US20110028422 Combination of nilotinib and a nitrogen mustard analogue for the treatment of chronic lymphocytic leukemia |
| 02/03/2011 | US20110028421 Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals |
| 02/03/2011 | US20110028420 Regression of Established Atherosclerotic Plaques, and Treating Sudden-Onset Asthma Attacks, using PARP Inhibitors |
| 02/03/2011 | US20110028418 Use of gabba receptor antagonists for the treatment of excessive sleepiness and disorders associated with excessive sleepiness |
| 02/03/2011 | US20110028417 Macrocyclic Compounds and Methods of Use Thereof |
| 02/03/2011 | US20110028416 Nutritional compositions for promotion of bone growth and maintenance of bone health comprising extracts of for example rosemary or caraway |
| 02/03/2011 | US20110028415 Use of 3-(indolyl)- or 3-(azaindolyl)-4-arylmaleimide derivatives in leukenia management |
| 02/03/2011 | US20110028414 Glucopyranoside derivatives |
| 02/03/2011 | US20110028413 Methods of Reducing Methotrexate Nephrotoxicity |
| 02/03/2011 | US20110028412 Herbal enhanced analgesic formulations |
| 02/03/2011 | US20110028411 Alpha-galactoceramide analogs, their methods of manufacture, intermediate compounds useful in these methods, and pharmaceutical compositions containing them |
| 02/03/2011 | US20110028410 Use of Amygdalin Analogues for the Treatment of Psoriasis |
| 02/03/2011 | US20110028408 diagnostic molecule and therapeutic target |
| 02/03/2011 | US20110028407 Enhancement of innate resistance to infection |
| 02/03/2011 | US20110028405 Sulfamides as zap-70 inhibitors |
| 02/03/2011 | US20110028400 Sulfated unsaturated disaccharidic chondroitin sulfate in connective tissue protection and repair |
| 02/03/2011 | US20110028396 Medical composition |
| 02/03/2011 | US20110028395 Peptide modulators of angiogenesis and use thereof |
| 02/03/2011 | US20110028390 Pyrazolospiroketone Acetyl-CoA Carboxylase Inhibitors |
| 02/03/2011 | US20110028382 Treatment of oral pharyngeal dysphagia |
| 02/03/2011 | US20110028320 Compositions and methods for controlling nematodes |
| 02/03/2011 | US20110027883 Rna interference mediating small rna molecules |
| 02/03/2011 | US20110027455 Sequestering subunit and related compositions and methods |
| 02/03/2011 | US20110027398 Methods of making olive juice extracts containing reduced solids |
| 02/03/2011 | US20110027397 Methods of treating autism spectrum disorders and compositions for same |
| 02/03/2011 | US20110027391 Liquid nucleotides/nucleosides-containing product |
| 02/03/2011 | US20110027389 Low Viscosity Liquid Polymeric Delivery System |
| 02/03/2011 | US20110027387 Nutritional supplement for use with poultry and livestock and method of using |
| 02/03/2011 | US20110027384 Photosensitising composition and its uses |
| 02/03/2011 | US20110027382 Solubilized benzoyl peroxyde acne |
| 02/03/2011 | US20110027378 Process of making flowable hemostatic compositions and devices containing such compositions |
| 02/03/2011 | US20110027377 Immediate release pharmaceutical granule compositions and a continuous process for making them |
| 02/03/2011 | US20110027374 Capecitabine rapidly disintegrating tablets |
| 02/03/2011 | US20110027373 Methods and compositions for modulating sialic acid production and treating hereditary inclusion body myopathy |
| 02/03/2011 | US20110027371 Nanoparticulate statin formulations and novel statin combinations |
| 02/03/2011 | US20110027369 Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients |
| 02/03/2011 | US20110027368 Polymeric compositions comprising therapeutic agents in crystalline phases, and methods of forming the same |
| 02/03/2011 | US20110027367 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
| 02/03/2011 | US20110027365 Patch Formulation For External Use |
| 02/03/2011 | US20110027362 Tablet having improved elution properties |
| 02/03/2011 | US20110027361 Extended release dosage form of paliperidone |
| 02/03/2011 | US20110027360 Pharmacokinetics of s-adenosylmethionine formulations |
| 02/03/2011 | US20110027359 Novel Pharmaceutical Compositions Comprising Levetiracetam |
| 02/03/2011 | US20110027358 Valsartan tablet formulations |
| 02/03/2011 | US20110027357 Compositions and methods for timed release of water-soluble nutritional supplements |
| 02/03/2011 | US20110027356 Combination of Oral Medicaments Bonded by a Wrapping |
| 02/03/2011 | US20110027354 Anti-parkinsonian compounds |
| 02/03/2011 | US20110027353 Therapeutic Delivery System |
| 02/03/2011 | US20110027352 Compounds for use in the treatment of neuropathic pain |
| 02/03/2011 | US20110027351 Liposomal formulations comprising an amphipathic weak base like tempamine for treatment of neurodegenerative conditions |
| 02/03/2011 | US20110027345 Composition containing rotigotine and use thereof and transdermal patch containing the composition |
| 02/03/2011 | US20110027342 S-adenosylmethionine formulations with enhanced bioavailability |
| 02/03/2011 | US20110027340 Implantable drug depot for weight control |
| 02/03/2011 | US20110027339 Porous implants and stents as controlled release drug delivery carriers |
| 02/03/2011 | US20110027336 Coatings for implantable devices comprising polymers of lactic acid and methods for fabricating the same |
| 02/03/2011 | US20110027327 Cosmetic or pharmaceutical composition for topical application |
| 02/03/2011 | US20110027326 External Composition for Skin |
| 02/03/2011 | US20110027325 Orally-administered agent |
| 02/03/2011 | US20110027324 O-desmethyl-venlafaxine for treating major depressive disorder |
| 02/03/2011 | US20110027323 Adjuvants and methods of use |
| 02/03/2011 | US20110027321 Chlamydia Vaccine Comprising HtrA Polypeptides |